Country Profile

Finland

Finland is a growing market for Indian pharmaceuticals — $63.9M in FY 2025–26, with 2.3× growth over the past decade. Medicines accounts for 94% of shipments. The compound annual growth rate since FY2015 stands at 7.7%.

🇫🇮 $63.9M · 2.3× growth since FY2015 · 7.7% CAGR
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$63.9M
Exports FY2025–26 DGCIS
2.3×
Growth FY2015→2026
7.7%
CAGR FY2015→2026
94%
Medicines Share
4
Product Categories Supplied
Finland is a growing market for Indian pharmaceuticals — $63.9M in FY 2025–26, with 2.3× growth over the past decade. Medicines accounts for 94% of shipments. The compound annual growth rate since FY2015 stands at 7.7%.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicines $60.3M (94.4%) Medicine Ingredients $2.54M (4.0%) Traditional & Herbal $644K (1.0%) Surgical & Hospital Supplies $412K (0.6%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Finland in the RBI overseas direct investment dataset (2011–2026).